Related Experiment Videos
Collection, processing and storage of peripheral blood stem cells (PBSC)
Haematologica
|March 1, 1991
Summary
Autologous blood stem cell transplantation (ABSCT) effectively mobilizes hemopoietic precursor cells for patients with hematological malignancies. This method utilizes chemotherapy to boost stem cell concentration in peripheral blood for collection and transplantation.
Area of Science:
- Hematology
- Oncology
- Stem Cell Transplantation
Background:
- Hematological malignancies pose significant treatment challenges.
- Autologous blood stem cell transplantation (ABSCT) is a critical therapeutic option.
- Effective mobilization of hemopoietic precursor cells is essential for successful ABSCT.
Purpose of the Study:
- To evaluate a method for mobilizing hemopoietic precursor cells into peripheral blood (PB).
- To assess the efficacy of collecting and cryopreserving these cells for ABSCT.
- To analyze the recovery and viability of cryopreserved stem cells post-thaw.
Main Methods:
- Mobilization of hemopoietic precursor cells via chemotherapy-induced myelosuppression and subsequent overshoot.
- Collection of peripheral blood stem cells using continuous flow leukapheresis (Fenwall CS 3000).
- Cryopreservation of mononuclear cell suspension in 10% DMSO in liquid nitrogen.
Main Results:
- A 15-20 fold increase in PB CFU-GM observed 15-20 days post-chemotherapy.
- Successful collection of peripheral blood stem cells during rapid platelet and WBC count recovery.
- Post-thaw CFU-GM recovery ranged from 13.8% to 81.5%, with 55-70% cell viability.
Conclusions:
- Chemotherapy-induced mobilization followed by leukapheresis is effective for collecting stem cells for ABSCT.
- Cryopreservation preserves stem cell viability and function for subsequent transplantation.
- This approach supports the application of ABSCT in patients with hematological malignancies.